Kidney Care Community News

Studies have shown patients with end-stage kidney disease treated with peritoneal dialysis perceive they have a higher quality of life than those who receive in-center hemodialysis.

Nephrologist Fredric Finkelstein, MD, thinks of reviewing art when he explains the value of using patient-reported outcome measures in his dialysis program.

An article suggesting thrice weekly doses of cinacalcet could manage certain aspects of bone and mineral metabolism in patients with chronic kidney disease who need treatment with dialysis appeared in Nephrology News and Issues.1

Most current nephrology fellows and 2020 graduates reported their education continued successfully during the COVID-19 pandemic and led to adequate preparation for practice, according to national survey findings.

Patients with end-stage kidney disease are at a disproportionately higher risk to become infected with COVID-19 and require hospitalization compared with older patients and those with disabilities.

In health care where emergent dialysis to manage kidney disease is part of the new normal, it is important that nurses consider all options – and viewpoints – as they build leadership skills, a speaker said.

InterWell Health closed a Series B, $46 million round of equity funding, partnering with more than 1,000 nephrologist investors and 55 nephrology practices across 31 states, according to a company press release.

An interim report by a National Kidney Foundation-American Society of Nephrology task force outlines challenges on the use of race in estimating GFR and suggests methods to evaluate new approaches to using it as a kidney function measure.

Approximately 20% of patients receiving in-center hemodialysis in the United States expressed hesitancy toward COVID-19 vaccination, according to a joint survey conducted by Stanford University School of Medicine and U.S. Renal Care.

Chronic kidney disease-mineral bone disorder is a systemic disorder prevalent among individuals with advanced chronic kidney disease and end-stage kidney disease.